Protection against inflammatory neurodegeneration and glial cell death by 7β-hydroxy epiandrosterone, a novel neurosteroid

Neurobiology of Disease

Volumn 15, Issue 2, 2004, Pages 262-268

  Dudas, Bertalan ^a   Hanin, Israel ^b   Rose, M ^b   Wülfert, Ernst ^c  

^a LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c Hunter Fleming Ltd   (United Kingdom)

Author keywords

7 hydroxy epiandrosterone; A (25 35); AF64A; Alzheimer's disease; Animal model; Neurodegeneration

Indexed keywords

7BETA HYDROXYEPIANDROSTERONE; AMYLOID BETA PROTEIN[25-35]; ETHYLCHOLINE MUSTARD AZIRIDINIUM; NEUROSTEROID; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CELL DEATH; CELL PROTECTION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; GLIA CELL; HIPPOCAMPUS; HORMONE ACTION; INFLAMMATION; MALE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SEPTUM NUCLEUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; AZIRIDINES; CELL DEATH; CHOLINE; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC FIBERS; DEHYDROEPIANDROSTERONE; DISEASE MODELS, ANIMAL; ENCEPHALITIS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NERVE DEGENERATION; NEUROGLIA; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; RATS; RATS, INBRED F344; SEPTAL NUCLEI; TAU PROTEINS;

EID: 1542270758     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2003.11.001     Document Type: Article

References (43)

1. Akwa Y., Sananes N., Gouezou M., Robel P., Baulieu E.E., Le Goascogne C. Astrocytes and neurosteroids: metabolism of pregnenolone and dehydroepiandrosterone. Regulation by cell density. J. Cell Biol. 121:1993;135-143.
2. Asaba H., Hosoya K., Takanaga H., Ohtsuki S., Tamura E., Takizawa T., Terasaki T. Blood-brain barrier is involved in the efflux transport of a neuroactive steroid, dehydroepiandrosterone sulfate, via organic anion transporting polypeptide 2. J. Neurochem. 75:2000;1907-1916.
3. Attal-Khemis S., Dalmeyda V., Morfin R. Change of 7alpha-hydroxy- dehydroepiandrosterone levels in serum of mice treated by cytochrome P450-modifying agents. Life Sci. 63:1998;1543-1553.
4. Barger S.W., Chavis J.A., Drew P.D. Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimulus-specific manner. J. Neurosci. Res. 62:2000;503-509.
5. Baulieu E.E., Thomas G., Legrain S., Lahlou N., Roger M., Debuire B., Faucounau V., Girard L., Hervy M.P., Latour F., Leaud M.C., Mokrane A., Pitti-Ferrandi H., Trivalle C., de Lacharriere O., Nouveau S., Rakoto-Arison B., Souberbielle J.C., Raison J., Le Bouc Y., Raynaud A., Girerd X., Forette F. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHE Age Study to a sociobiomedical issue. Proc. Natl. Acad. Sci. U. S. A. 97:2000;4279-4284.
6. Brown R.C., Papadopoulos V. Region-specific increase in peripheral-type benzodiazepine receptor binding and neurosteroid formation in Alzheimer's disease. Abstr. - Soc. Neurosci. 2000.
7. Brown R.C., Cascio C., Papadopoulos V. Pathways of neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and beta-amyloid peptide. J. Neurochem. 74:2000;847-859.
8. Diamond D.M., Branch B.J., Fleshner M. The neurosteroid dehydroepiandrosterone sulfate (DHEAS) enhances hippocampal primed burst, but not long-term, potentiation. Neurosci. Lett. 202:1996;204-208.
9. El Tamer A., Corey J., Wulfert E., Hanin I. Reversible cholinergic changes induced by AF64A in rat hippocampus and possible septal compensatory effect. Neuropharmacology. 31:1992;397-402.
10. Fisher A., Hanin I. Potential animal models for senile dementia of Alzheimer's type, with emphasis on AF64A-induced cholinotoxicity. Annu. Rev. Pharmacol. Toxicol. 26:1986;161-181.
11. Flood J.F., Roberts E. Dehydroepiandrosterone sulfate improves memory in aging mice. Brain Res. 448:1988;178-181.
12. Flood J.F., Smith G.E., Roberts E. Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res. 447:1988;269-278.
13. Flood J.F., Farr S.A., Johnson D.A., Li P.K., Morley J.E. Peripheral steroid sulfatase inhibition potentiates improvement of memory retention for hippocampally administered dehydroepiandrosterone sulfate but not pregnenolone sulfate. Psychoneuroendocrinology. 24:1999;799-811.
14. Geddes J.W., Schwab C., Craddock S., Wilson J.L., Pettigrew L.C. Alterations in tau immunostaining in the rat hippocampus following transient cerebral ischemia. J. Cereb. Blood Flow Metab. 14:1994;554-564.
15. Goodman Y., Bruce A.J., Cheng B., Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J. Neurochem. 66:1996;1836-1844.
16. Green P.S., Yang S.H., Simpkins J.W. Neuroprotective effects of phenolic A ring oestrogens. Novartis Found. Symp. 230:2000;202-213.
17. Hanin I. The AF64A model of cholinergic hypofunction: an update. Life Sci. 58:1996;1955-1964.
18. Irving E.A., Nicoll J., Graham D.I., Dewar D. Increased tau immunoreactivity in oligodendrocytes following human stroke and head injury. Neurosci. Lett. 213:1996;189-192.
19. Irving E.A., Yatsushiro K., McCulloch J., Dewar D. Rapid alteration of tau in oligodendrocytes after focal ischemic injury in the rat: involvement of free radicals. J. Cereb. Blood Flow Metab. 17:1997;612-622.
20. Jellinck P.H., Lee S.J., McEwen B.S. Metabolism of dehydroepiandrosterone by rat hippocampal cells in culture: possible role of aromatization and 7-hydroxylation in neuroprotection. J. Steroid Biochem. Mol. Biol. 78:2001;313-317.
21. Kim S.B., Hill M., Kwak Y.T., Hampl R., Jo D.H., Morfin R. Neurosteroids: cerebrospinal fluid levels for Alzheimer's disease and vascular dementia diagnostics. J. Clin. Endocrinol. Metab. 2003;. (in press).
22. Kimonides V.G., Khatibi N.H., Svendsen C.N., Sofroniew M.V., Herbert J. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 95:1998;1852-1857.
23. Lapchak P.A., Araujo D.M. Preclinical development of neurosteroids as neuroprotective agents for the treatment of neurodegenerative diseases. Int. Rev. Neurobiol. 46:2001;379-397.
24. Leutner S., Czech C., Schindowski K., Touchet N., Eckert A., Muller W.E. Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations. Neurosci. Lett. 292:2000;87-90.
25. Lewis J.G., George P.M., Elder P.A. Plasma androsterone/epiandrosterone sulfates as markers of 5 alpha-reductase activity: effect of finasteride in normal men. Steroids. 62:1997;632-635.
26. Lovell M.A., Ehmann W.D., Mattson M.P., Markesbery W.R. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging. 18:1997;457-461.
27. Maneesub Y., Sanvarinda Y., Govitrapong P. Partial restoration of choline acetyltransferase activities in aging and AF64A-lesioned rat brains by vitamin E. Neurochem. Int. 22:1993;487-491.
28. Marcus D.L., Thomas C., Rodriguez C., Simberkoff K., Tsai J.S., Strafaci J.A., Freedman M.L. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp. Neurol. 150:1998;40-44.
29. Markesbery W.R. The role of oxidative stress in Alzheimer disease. Arch. Neurol. 56:1999;1449-1452.
30. Nunomura A., Perry G., Pappolla M.A., Friedland R.P., Hirai K., Chiba S., Smith M.A. Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J. Neuropathol. Exp. Neurol. 59:2000;1011-1017.
31. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60:2001;759-767.
32. Papadopoulos M.C., Koumenis I.L., Yuan T.Y., Giffard R.G. Increasing vulnerability of astrocytes to oxidative injury with age despite constant antioxidant defenses. Neuroscience. 82:1998;915-925.
33. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, London.
34. Pratico D., Clark C.M., Lee V.M., Trojanowski J.Q., Rokach J., FitzGerald G.A. Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity. Ann. Neurol. 48:2000;809-812.
35. Pratico D., Uryu K., Leight S., Trojanoswki J.Q., Lee V.M. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21:2001;4183-4187.
36. Pringle A.K., Schmidt W., Deans J.K., Wulfert E., Reymann K.G., Sundstrom L.E. 7-hydroxylated epiandrosterone (7-OH-EPIA) reduces ischaemia-induced neuronal damage both in vivo and in vitro. Eur. J. Neurosci. 18:2003;1-8.
37. Ramassamy C., Averill D., Beffert U., Bastianetto S., Theroux L., Lussier-Cacan S., Cohn J.S., Christen Y., Davignon J., Quirion R., Poirier J. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Radical Biol. Med. 27:1999;544-553.
38. Roberts E., Bologa L., Flood J.F., Smith G.E. Effects of dehydroepiandrosterone and its sulfate on brain tissue in culture and on memory in mice. Brain Res. 406:1987;357-362.
39. Sigurdsson E.M., Lorens S.A., Hejna M.J., Dong X.W., Lee J.M. Local and distant histopathological effects of unilateral amyloid-beta 25-35 injections into the amygdala of young F344 rats. Neurobiol. Aging. 17:1996;893-901.
40. Swanson L.W. Brain Maps: Structure of the Rat Brain. 1998;Elsevier, Amsterdam.
41. Tuppo E.E., Forman L.J., Spur B.W., Chan-Ting R.E., Chopra A., Cavalieri T.A. Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease. Brain Res. Bull. 54:2001;565-568.
42. Weill-Engerer S., David J.P., Sazdovitch V., Liere P., Schumacher M., Delacourte A., Baulieu E.E., Akwa Y. In vitro metabolism of dehydroepiandrosterone (DHEA) to 7alpha-hydroxy-DHEA and Delta5-androstene- 3beta,17beta-diol in specific regions of the aging brain from Alzheimer's and non-demented patients. Brain Res. 969:2003;117-125.
43. Yoo A., Harris J., Dubrovsky B. Dose-response study of dehydroepiandrosterone sulfate on dentate gyrus long-term potentiation. Exp. Neurol. 137:1996;151-156.